Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
| Descriptor ID |
D054218
|
| MeSH Number(s) |
C04.557.337.428.600.620 C15.604.515.560.600.620 C20.683.515.528.600.620
|
| Concept/Terms |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic, Acute, T Cell
- Leukemia, Lymphoblastic, Acute, T-Cell
- Leukemia, Lymphocytic, Acute T Cell
- Leukemia, Lymphocytic, Acute, T-Cell
- Leukemia, T-Cell, Acute
- T-Lymphocytic Leukemia, Acute
- Acute T-Lymphocytic Leukemia
- Acute T-Lymphocytic Leukemias
- Leukemia, Acute T-Lymphocytic
- Leukemias, Acute T-Lymphocytic
- T Lymphocytic Leukemia, Acute
- T-Lymphocytic Leukemias, Acute
- Lymphoblastic Leukemia, Acute, T-Cell
- Lymphocytic Leukemia, T Cell, Acute
- Lymphocytic Leukemia, T-Cell, Acute
- Precursor T-Cell Lymphoblastic Leukemia
- Precursor T Cell Lymphoblastic Leukemia
- Precursor T-Cell Lymphoblastic Lymphoma
- Precursor T Cell Lymphoblastic Lymphoma
- T-ALL
- T-Cell Leukemia, Acute
- Acute T-Cell Leukemia
- Acute T-Cell Leukemias
- Leukemia, Acute T-Cell
- Leukemias, Acute T-Cell
- T Cell Leukemia, Acute
- T-Cell Leukemias, Acute
- T-Cell Acute Lymphocytic Leukemia
- Lymphoblastic Leukemia, Acute, T Cell
|
Below are MeSH descriptors whose meaning is more general than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in this website by year, and whether "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 |
| 2017 | 2 | 1 | 3 |
| 2018 | 4 | 0 | 4 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1258-e1259.
-
SARS-CoV-2 Infection During Induction Chemotherapy in a Child With High-risk T-Cell Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol. 2021 08 01; 43(6):e804-e807.
-
COVID-19 reinfection in two children with cancer. Pediatr Hematol Oncol. 2021 05; 38(4):403-405.
-
Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR. Leuk Res. 2021 01; 100:106473.
-
ETP-ALL with aberrant B marker expression: Case series and a brief review of literature. Int J Lab Hematol. 2019 04; 41(2):e32-e37.
-
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Br J Haematol. 2018 09; 182(5):705-711.
-
Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia. Cancer Lett. 2018 05 28; 422:107-117.
-
Mutant IL-7Ra and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia. Leukemia. 2018 08; 32(8):1795-1882.
-
Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia. Int J Nanomedicine. 2017; 12:8025-8034.
-
Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia. Exp Hematol. 2017 09; 53:16-25.